Article
Development of a CRISPR/dCas9-based membrane-assisted colorimetric assay for detection of high-risk HPV16 and HPV18: a proof-of-concept study.
Molecular biology reports - 4 Jul 2026
Tamrakar Vaibhav Kumar, Sharma Kuldeep, Singh Pushpendra, Bhargava Anudita, Thakur Pushpawati, Negi Sanjay Singh
Abstract excerpt
BACKGROUND AND AIMS: Persistent infection with high-risk human papillomavirus (HR-HPV), particularly HPV16 and HPV18, is the leading cause of cervical cancer. While molecular diagnostics offer high sensitivity, their deployment in decentralized settings remains limited. This study presents a proof-of-concept CRISPR/dCas9-based membrane-assisted detection platform for HR-HPV genotyping. METHODS: A membrane-based...
Topics
Join the communities discussing this publication.
